Advertisement
PerkinElmer
PerkinElmer

The Scientist

» biotech

Most Recent

image: DNA for the Masses

DNA for the Masses

By | October 31, 2012

An Israeli company plans to synthesize DNA on demand for anyone, including those outside of research labs.  

1 Comment

image: IP Lawsuits Settled

IP Lawsuits Settled

By | September 5, 2012

Two lawsuits against prominent researcher Craig Thompson for allegedly failing to share intellectual property with his institution lead to a licensing agreement on cancer diagnostics.

0 Comments

image: The Little Cell That Could

The Little Cell That Could

By | July 1, 2012

Critics point out that cell therapy has yet to top existing treatments. Biotech companies are setting out to change that—and prove that the technology can revolutionize medicine.

1 Comment

image: Opinion: On the Up and Up

Opinion: On the Up and Up

By | June 20, 2012

An Amgen executive refutes accusations that the company published misleading results of its mid-90s clinical trial testing an anemia drug.

5 Comments

image: Best Places to Work Industry, 2012

Best Places to Work Industry, 2012

By | June 1, 2012

Much has changed in the 10 years since our first survey of industry researchers. Large companies are now looking to small, nimble ones for services as well as innovation.

0 Comments

image: Demand for Biotech Tax Breaks

Demand for Biotech Tax Breaks

By | May 30, 2012

A NJ senator and BIO are beating the drum to reinstitute a law that would channel millions into small life science companies around the country.

0 Comments

image: Sanofi Thief Reprimanded

Sanofi Thief Reprimanded

By | May 8, 2012

A former Sanofi research scientist is sentenced to 18 months in prison for stealing trade secrets.

0 Comments

image: Pharma Puts Up Money for Biotech

Pharma Puts Up Money for Biotech

By | March 21, 2012

GlaxoSmithKline and Johnson & Johnson contribute a total of $100 million to early-stage biotech endeavors.

0 Comments

image: Self-prescribing Patients?

Self-prescribing Patients?

By | March 13, 2012

The FDA considers making some drugs for diabetes, asthma, and other ailments available over the counter.

4 Comments

image: Opinion: On the Gene Patent Debate

Opinion: On the Gene Patent Debate

By | March 7, 2012

Two key patent cases that no doubt will impact the future of personalized medicine are pending review by the US Supreme Court. What will the Court decide?

18 Comments

Advertisement

Popular Now

  1. Opinion: Too Many Mitochondrial Genome Papers
  2. Antibiotics and the Gut Microbiome
  3. Sex Differences in Pain Pathway
  4. Anti-Vax Doctor Found Dead
    The Nutshell Anti-Vax Doctor Found Dead

    Police are calling the death of James Bradstreet, a physician who claimed vaccines cause autism and offered autism cures to patients, an apparent suicide.

Advertisement
Shimadzu Scientific
Shimadzu Scientific
Advertisement
The Scientist